Terms: = Uterine cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH
99 results:
1. Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
Tewari KS; Colombo N; Monk BJ; Dubot C; Cáceres MV; Hasegawa K; Shapira-Frommer R; Salman P; Yañez E; Gümüs M; Olivera Hurtado de Mendoza M; Samouëlian V; Castonguay V; Arkhipov A; Tekin C; Li K; Toker S; Keefe SM; Lorusso D
JAMA Oncol; 2024 Feb; 10(2):185-192. PubMed ID: 38095881
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
Wang T; Luan L; Deng J; Liu N; Wu Q; Gong T; Zhu J; Zhang Z; Zhang J
Hum Vaccin Immunother; 2023 Aug; 19(2):2241309. PubMed ID: 37519009
[TBL] [Abstract] [Full Text] [Related]
3. Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result-based analysis.
Xue Q; Che W; Xue L; Zhang X; Wang X; Lyu J
Cancer Med; 2023 May; 12(9):10917-10930. PubMed ID: 36924355
[TBL] [Abstract] [Full Text] [Related]
4. Cemiplimab as Second-Line Therapy for Patients with Recurrent Cervical cancer: A United States-based Cost-effectiveness Analysis.
Liu K; Zhu Y; Zhou Y; Zhu H
Adv Ther; 2023 Apr; 40(4):1838-1849. PubMed ID: 36870042
[TBL] [Abstract] [Full Text] [Related]
5. Suicide Risk Among Individuals Diagnosed With cancer in the US, 2000-2016.
Hu X; Ma J; Jemal A; Zhao J; Nogueira L; Ji X; Yabroff KR; Han X
JAMA Netw Open; 2023 Jan; 6(1):e2251863. PubMed ID: 36662522
[TBL] [Abstract] [Full Text] [Related]
6. Validation of the QLQ-CAX24 instrument in cervical cancer and its association with cachexia classifications.
Luvián-Morales J; Castillo-Aguilar J; Delgadillo-González M; Cisneros-Sánchez A; Bosch-Gutiérrez J; Castro-Eguiluz D; Cetina-Pérez L; Oñate-Ocaña LF
Jpn J Clin Oncol; 2023 Mar; 53(4):304-312. PubMed ID: 36579766
[TBL] [Abstract] [Full Text] [Related]
7. Underscreening, overscreening, and guideline-adherent cervical cancer screening in a national cohort.
Lee YW; Morgan JR; Fiascone S; Perkins RB
Gynecol Oncol; 2022 Nov; 167(2):181-188. PubMed ID: 36150914
[TBL] [Abstract] [Full Text] [Related]
8. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
9. Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer.
Bogani G; Donato VD; Scambia G; Landoni F; Ghezzi F; Muzii L; Panici PB; Raspagliesi F;
Gynecol Oncol; 2022 Sep; 166(3):561-566. PubMed ID: 35909005
[TBL] [Abstract] [Full Text] [Related]
10. The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.
Leitao MM; Zhou QC; Brandt B; Iasonos A; Sioulas V; Lavigne Mager K; Shahin M; Bruce S; Black DR; Kay CG; Gandhi M; Qayyum M; Scalici J; Jones NL; Paladugu R; Brown J; Naumann RW; Levine MD; Mendivil A; Lim PC; Kang E; Cantrell LA; Sullivan MW; Martino MA; Kratz MK; Kolev V; Tomita S; Leath CA; Boitano TKL; Doo DW; Feltmate C; Sugrue R; Olawaiye AB; Goldfeld E; Ferguson SE; Suhner J; Abu-Rustum NR
Gynecol Oncol; 2022 Sep; 166(3):417-424. PubMed ID: 35879128
[TBL] [Abstract] [Full Text] [Related]
11. Integrated bioinformatics data analysis reveals a risk signature and PKD1 induced progression in endometrial cancer patients with postmenopausal status.
Cheng Y; Zhang S; Qiang Y; Dong L; Li Y
Aging (Albany NY); 2022 Jul; 14(13):5554-5570. PubMed ID: 35816294
[TBL] [Abstract] [Full Text] [Related]
12. Adverse Urinary System Outcomes among Older Women with Endometrial cancer.
Anderson C; Lund JL; Park J; Brewster W; Bae-Jump V; Olshan AF; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1508. PubMed ID: 35775217
[TBL] [Abstract] [Full Text] [Related]
13. Male-origin microchimerism and endometrial cancer: A prospective case-cohort study.
Hallum S; Petersen GL; Jakobsen MA; Pinborg A; Kuhlmann C; Tjønneland A; Kamper-Jørgensen M
Cancer Epidemiol; 2022 Aug; 79():102169. PubMed ID: 35526517
[TBL] [Abstract] [Full Text] [Related]
14. Cervical intraepithelial neoplasia in women with transformation zone type 3: cervical biopsy versus large loop excision.
Gustafson LW; Hammer A; Bennetsen MH; Kristensen CB; Majeed H; Petersen LK; Andersen B; Bor P
BJOG; 2022 Dec; 129(13):2132-2140. PubMed ID: 35488417
[TBL] [Abstract] [Full Text] [Related]
15. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma.
Ye S; Zhou S; Zhong S; Shan B; Jiang W; Yang W; Cai X; Yang H
BMC Cancer; 2022 Apr; 22(1):449. PubMed ID: 35461222
[TBL] [Abstract] [Full Text] [Related]
16. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic cancers.
Noh JJ; Kim MK; Choi MC; Lee JW; Park H; Jung SG; Joo WD; Song SH; Lee C
Cancer Res Treat; 2022 Oct; 54(4):1200-1208. PubMed ID: 34902958
[TBL] [Abstract] [Full Text] [Related]
17. Prevalence and spatial heterogeneity of Trichomonas vaginalis infection among the female population and association with climate in Guangxi Zhuang autonomous region, Southern China.
Lu H; He H; He X; Liu Q; Mo C; Li M; Chen M; Qin J; Zhang Z
Acta Trop; 2022 Jan; 225():106204. PubMed ID: 34688632
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative controlling nutritional status (CONUT) score is a prognostic factor for early-stage cervical cancer patients with high-risk factors.
Zhang G; Zhang Y; He F; Wu H; Wang C; Fu C
Gynecol Oncol; 2021 Sep; 162(3):763-769. PubMed ID: 34148719
[TBL] [Abstract] [Full Text] [Related]
19. Comparison Between 360° 3-D Transvaginal Ultrasound and Magnetic Resonance Imaging for Assessment of Vaginal Invasion in Cervical cancer: A Preliminary Report.
Zhu Y; Lu M; Dai KJ; Liu C; He R
Ultrasound Med Biol; 2021 Aug; 47(8):2250-2257. PubMed ID: 34020846
[TBL] [Abstract] [Full Text] [Related]
20. Cytoplasmic Pattern p53 Immunoexpression in Pelvic and Endometrial Carcinomas With TP53 Mutation Involving Nuclear Localization Domains: An Uncommon But Potential Diagnostic Pitfall With Clinical Implications.
Rabban JT; Garg K; Ladwig NR; Zaloudek CJ; Devine WP
Am J Surg Pathol; 2021 Nov; 45(11):1441-1451. PubMed ID: 33899789
[TBL] [Abstract] [Full Text] [Related]
[Next]
